OrthoLogic
This article was originally published in The Gray Sheet
Executive Summary
Nets approximately $12 mil. from its initial public offering of 2 mil. shares of common stock at $6.50 each. Hanifen, Imhoff underwrote the offering. The bone growth stimulator manufacturer had submitted a preliminary prospectus in April with Vector Securities International and Kemper Securities Group as underwriters ("The Gray Sheet" May 25, p. 16).